Pfizer to provide another 100M COVID-19 vaccine doses to EU

By Chris Newmarker | December 29, 2020

Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that they will provide an extra 100 million doses of its Comirnaty COVID-19 vaccine to EU member countries in 2021.

“In partnership with the European Commission, member states and healthcare providers, we will be able to reach a total of 150 million Europeans across the continent,” Pfizer CEO Albert Bourla said in a news release.

The announcement comes a week after Pfizer announced an extra 100 million doses for the U.S.

The EU is now set to receive a total 300 million doses of Comirnaty; the U.S. will receive 200 million. Pfizer and BioNTech have previously said they expect to manufacture up to 1.3 billion doses worldwide by the end of 2021.

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].